Skip to Main Content

Author Details

Amber L Johns
Garvan Institute of Medical Research and The Kinghorn Cancer Centre
2009
51
28
PMIDPaper TitleJournal TitlePublished Year
36767006Framework for Adoption of Next-Generation Sequencing (NGS) Globally in the Oncology Area.Healthcare (Basel)2023
36725142Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission.Lancet Oncol2023
36745763The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer.Ann Surg2023
36603918ICGC-ARGO precision medicine: an update on targeted therapy based on longitudinal analysis of tumour heterogeneity and evolution in colorectal cancer.Lancet Oncol2023
34973218ICGC-ARGO precision medicine: familial matters in pancreatic cancer.Lancet Oncol2022
35358454ICGC-ARGO precision medicine: targeted therapy according to longitudinal assessment of tumour heterogeneity in colorectal cancer.Lancet Oncol2022
35589842Neoantigen quality predicts immunoediting in survivors of pancreatic cancer.Nature2022
36548810Empowering quality data - the Gordian knot of bringing real innovation into healthcare system.Diagnosis (Berl)2022
35901820ICGC-ARGO precision medicine: an update on familial matters in pancreatic cancer.Lancet Oncol2022
36360466Fighting Cancer around the World: A Framework for Action.Healthcare (Basel)2022
33980655Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition.Cancer Res2021
35072136GA4GH: International policies and standards for data sharing across genomic research and healthcare.Cell Genom2021
34496934Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants.Hered Cancer Clin Pract2021
34586840Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status.Sci Adv2021
34399810Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants.Hered Cancer Clin Pract2021
34748551Return of individual research results from genomic research: A systematic review of stakeholder perspectives.PLoS One2021
32675551Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer.Ann Surg2020
31735913MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma.Oncogene2020
31745186Development and validation of a targeted gene sequencing panel for application to disparate cancers.Sci Rep2019
31666883Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program.Hered Cancer Clin Pract2019
29080858Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer.Gut2018
30102688Provenance and risk in transfer of biological materials.PLoS Biol2018
27856273Hypermutation In Pancreatic Cancer.Gastroenterology2017
28199314Whole-genome landscape of pancreatic neuroendocrine tumours.Nature2017
28381539Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.Sci Transl Med2017
28454591Lost in translation: returning germline genetic results in genome-scale cancer research.Genome Med2017
28953865Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours.Nature2017
27999205MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivity.Oncotarget2017
26909576Genomic analyses identify molecular subtypes of pancreatic cancer.Nature2016
27889644Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids.Neoplasia2016
26804919Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.Cell Rep2016
25544769βIII-tubulin: a novel mediator of chemoresistance and metastases in pancreatic cancer.Oncotarget2015
25896973Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial.Clin Cancer Res2015
25719666Whole genomes redefine the mutational landscape of pancreatic cancer.Nature2015
24263063Adjuvant chemotherapy in elderly patients with pancreatic cancer.Br J Cancer2014
25313458Clinical and pathologic features of familial pancreatic cancer.Cancer2014
24976722Personalising pancreas cancer treatment: When tissue is the issue.World J Gastroenterol2014
24963353Returning individual research results for genome sequences of pancreatic cancer.Genome Med2014
24500968Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling.Int J Cancer2014
23439753Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.J Clin Oncol2013
24250782Somatic point mutation calling in low cellularity tumors.PLoS One2013
24004612Clinical and molecular characterization of HER2 amplified-pancreatic cancer.Genome Med2013
23660961Understanding pancreatic cancer genomes.J Hepatobiliary Pancreat Sci2013
22204713The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.Hum Pathol2012
23049875qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profiles.PLoS One2012
23103869Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.Nature2012
22241899The prognostic and predictive value of serum CA19.9 in pancreatic cancer.Ann Oncol2012
21261715Clinical and immunohistochemical features of 34 solid pseudopapillary tumors of the pancreas.J Gastroenterol Hepatol2011
21577321Upregulation of the signal transducers and activators of transcription 3 (STAT3) pathway in lymphatic metastases of papillary thyroid cancer.Int J Clin Exp Pathol2011
19320058Synoptic reporting improves histopathological assessment of pancreatic resection specimens.Pathology2009
  • 1 - 50 of 51

Recommended Authors

Julie M Wilson
Ontario Institute for Cancer Research
Career Start Year 2016
Number of shared co-authors 15
Daniel Vod??k
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 12
Patrick W Underwood
College of Medicine, University of Florida
Career Start Year 2014
Number of shared co-authors 0
Sahil Seth
The University of Texas MD Anderson Cancer Center
Career Start Year 2014
Number of shared co-authors 24
Dianne Chadwick
University Health Network
Career Start Year 2013
Number of shared co-authors 16
Ashton A Connor
Houston Methodist Hospital
Career Start Year 2012
Number of shared co-authors 15
Gun Ho Jang
Ontario Institute for Cancer Research
Career Start Year 2011
Number of shared co-authors 15
Jeran K Stratford
Research Triangle Institute (RTI)
Career Start Year 2009
Number of shared co-authors 0
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 9
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 3
John Paul Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 2
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 7
Florencia McAllister
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 2
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 2
Jennifer B Permuth
Moffitt Cancer Center
Career Start Year 2004
Number of shared co-authors 4
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 5
Umesh Bhanot
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 5
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 13
Eric A Collisson
University of California san francisco
Career Start Year 1999
Number of shared co-authors 6
Thomas J George
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 11
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 6
Sudhir Srivastava
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 2
Paul T Fanta
University of California San Diego Moores Cancer Center
Career Start Year 1992
Number of shared co-authors 1
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 15
Kerrington D Smith
Dartmouth-Hitchcock Medical Center
Career Start Year 1991
Number of shared co-authors 0
Nathan Bahary
University of Pittsburgh
Career Start Year 1989
Number of shared co-authors 1
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Career Start Year 1986
Number of shared co-authors 7
Andrew M Lowy
University of California San Diego
Career Start Year 1985
Number of shared co-authors 4
Francisco X Real
Spanish National Cancer Research Centre-CNIO
Career Start Year 1983
Number of shared co-authors 16

Collaborators

Sean M Grimmond
The University of Melbourne
Co-authored papers 17
Nicola Waddell
QIMR Berghofer Medical Research Institute
Co-authored papers 16
Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 16
John V Pearson
QIMR Berghofer Medical Research Institute
Co-authored papers 13
Katia Nones
QIMR Berghofer Medical Research Institute
Co-authored papers 11
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Co-authored papers 10
Karin S Kassahn
Adelaide Medical School, The University of Adelaide
Co-authored papers 10
J Lynn Fink
The University of Queensland Diamantina Institute, The University of Queensland
Co-authored papers 9
Nikolajs Zeps
Queensland University of Technology
Co-authored papers 8
Richard A Gibbs
Baylor College of Medicine
Co-authored papers 5
David A Wheeler
Baylor College of Medicine
Co-authored papers 5
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Angela Steinmann
The Garvan Institute of Medical Research
Co-authored papers 4
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 3
Oliver Hofmann
University of Melbourne
Co-authored papers 2
Eva C Winkler
National Centre for Tumour Diseases, University Hospital
Co-authored papers 2
Gloria M Petersen
Mayo Clinic
Co-authored papers 2
Huyen Dinh
Institute of Advanced Energy, Kyoto University
Co-authored papers 2
Adrienne Morey
The Canberra Hospital
Co-authored papers 2
Thomas John
Peter MacCallum Cancer Centre
Co-authored papers 2
Richard D Schulick
University of Colorado School of Medicine
Co-authored papers 2
Danya F Vears
University of Melbourne
Co-authored papers 2
Yi Han
Baylor College of Medicine
Co-authored papers 2
Yingxiao Wang
Co-authored papers 2
M??lanie Courtot
Ontario Institute for Cancer Research
Co-authored papers 2
Stephanie O M Dyke
Montreal Neurological Institute, McGill University
Co-authored papers 2
Bartha Maria Knoppers
McGill University
Co-authored papers 2
Christina K Yung
Ontario Institute for Cancer Research
Co-authored papers 2
Donna M Muzny
Baylor College of Medicine
Co-authored papers 2
Clara Gaff
Murdoch Children's Research Institute
Co-authored papers 2
Release 1.2